Instead of a diverse, Firmicutes-enriched microbiome that promotes intestinal Treg cell population and immune tolerance (34, 35, 45), the dysbiotic microbiome in IBD patients supports pathogenic CD4+ type-17 T helper (TH17) cells in the intestine. Here, CD4 is linked to inflammatory bowel disease.